Transfected Stable Cell Lines
Reliable | High-Performance | Wide Rage
Precision reporter, kinase, immune receptor, biosimilar, Cas9, and knockout stable cell lines for diverse applications.
Cat. No. : CSC-SC005703
Host Cell : HEK293 (CHO and other cell types are also available) Size : >1x106 frozen cells/vial
| Cat. No. | CSC-SC005703 |
| Description | Using Creative Biogene's proprietary lentiviral vectors, we subclone the target gene into lentivector, generate the lentivirus particles, sequentially infect the cell line HEK293 (other cell types are also available according to your requirements), and select the clones constantly expressing target gene at high level. |
| Target Gene | FGF2 |
| Gene Species | Homo sapiens (Human) |
| Host Cell | HEK293 (CHO and other cell types are also available) |
| Host Cell Species | Species varies |
| Applications |
1. Gene expression studies 2. Signaling pathway research 3. Drug screening and toxicology 4. Disease research |
| Size | 2 × 10^6 cells / vial |
| Stability | Validated for at least 10 passages |
| Quality Control | Negative for bacteria, yeast, fungi and mycoplasma. |
| Storage | Liquid nitrogen |
| Shipping | Dry Ice |
| Revival | Rapidly thaw cells in a 37°C water bath. Transfer contents into a tube containing pre-warmed media. Centrifuge cells and seed into a 25 cm2 flask containing pre-warmed media. |
| Mycoplasma | Negative |
| Format | One frozen vial containing millions of cells |
| Storage | Liquid nitrogen |
| Safety Considerations |
The following safety precautions should be observed. 1. Use pipette aids to prevent ingestion and keep aerosols down to a minimum. 2. No eating, drinking or smoking while handling the stable line. 3. Wash hands after handling the stable line and before leaving the lab. 4. Decontaminate work surface with disinfectant or 70% ethanol before and after working with stable cells. 5. All waste should be considered hazardous. 6. Dispose of all liquid waste after each experiment and treat with bleach. |
| Ship | Dry ice |
| Gene Name | FGF2 fibroblast growth factor 2 (basic) [ Homo sapiens ] |
| Gene Symbol | FGF2 |
| Synonyms | BFGF; FGFB; FGF-2; HBGF-2 |
| Gene Description | fibroblast growth factor 2 (basic) |
| GeneID | 2247 |
| Uni ProtID | P09038 |
| mRNA Refseq | NM_002006.4 |
| Protein Refseq | NP_001997.5 |
| Chromosome Location | 4q26 |
| Function | chemoattractant activity; cytokine activity; fibroblast growth factor binding; fibroblast growth factor receptor binding; growth factor activity; heparin binding; ligand-dependent nuclear receptor transcription coactivator activity; protein binding; voltage-gated calcium channel activity; |
| Pathway | Activated point mutants of FGFR2, organism-specific biosystem; Adaptive Immune System, organism-specific biosystem; Angiogenesis, organism-specific biosystem; Angiopoietin receptor Tie2-mediated signaling, organism-specific biosystem; Constitutive PI3K/AKT Signaling in Cancer, organism-specific biosystem; DAP12 interactions, organism-specific biosystem; DAP12 signaling, organism-specific biosystem; |
| MIM | 134920 |
Diabetic wounds severely compromise patients' physical and mental health, creating an urgent need for novel therapeutic strategies and materials. Macrophages play a pivotal role in tissue repair mechanisms. Macrophage-conditioned medium contains various proteins and cytokines associated with wound healing, demonstrating the potential to promote the healing of diabetic wounds; furthermore, engineering macrophages offers a promising approach to further enhance their tissue repair capabilities. Fibroblast growth factor 2 (FGF2) is a key growth factor in the wound healing process. In this study, researchers successfully engineered a stable macrophage cell line that overexpresses FGF2 (engineered macrophages). Proteomic analysis indicated that conditioned medium derived from these FGF2-overexpressing macrophages could promote wound healing, likely by enhancing vascularization. Additionally, in vitro experiments confirmed that the conditioned medium promoted endothelial cell migration. To facilitate drug delivery and application to the wound site, the researchers fabricated soluble hyaluronic acid microneedles loaded with this conditioned medium. These soluble microneedles exhibited excellent mechanical properties and biocompatibility, effectively releasing their cargo in vivo. In a full-thickness skin defect model using diabetic mice, the microneedles significantly accelerated wound healing and markedly promoted angiogenesis and collagen deposition.
Scratch assay results showed that EA.hy926 cells treated with conditioned medium from FGF2-overexpressing macrophages (FGF2 OE group) and conditioned medium from macrophages (RAW 264.7 CM group) exhibited significantly enhanced migratory ability at 24 hours (Figure 1A). Notably, the FGF2 OE group demonstrated the strongest capacity to promote cell migration (Figure 1B). The wound treatment process is illustrated in Figure 1D and F: a full-thickness skin wound model was established in diabetic mice, followed by treatment with Control, MN, CM + MN, or FGF2 OE CM + MN. Macroscopic observation revealed that the FGF2 OE CM + MN group exhibited the fastest wound healing rate; by day 12, the wounds had almost completely closed, and new skin had formed. Although the MN and CM + MN groups also showed faster wound healing than the Control group, their performance was inferior to that of the FGF2 OE CM + MN group (Figure 1E). These results indicate that the combination of conditioned medium from FGF2-overexpressing macrophages and microneedles (FGF2 OE CM + MN) significantly promotes diabetic wound healing. Furthermore, there were no significant differences in body weight among the groups (Figure 1C).
Figure 1. Macrophages conditioned medium promoted wound healing in vitro and in vivo. (Wang H Y, et al., 2025)
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
Write a review of your use of Biogene products and services in your research. Your review can help your fellow researchers make informed purchasing decisions.